 |
|
Application of C5 inhibitors in glomerular diseases in 2021
Alexis Werion, Eric Rondeau
Kidney Res Clin Pract. 2022;41(4):412-421. Published online 2022 Mar 15 DOI: https://doi.org/10.23876/j.krcp.21.248
|
|
Citations to this article as recorded by
 Farmacocinética de eculizumab en pacientes adultos y pediátricos con síndrome hemolítico urémico atípico y glomerulopatía C3
Alba Pau Parra, Natalia Ramos, Janire Perurena-Prieto, Silvia Manrique-Rodríguez, Monica Climente, Laura García Quintanilla, Ángel Escolano, Marta Miarons
Farmacia Hospitalaria.2024; 48(1): 16. CrossRef [Translated article] Pharmacokinetics of eculizumab in adult and pediatric patients with atypical hemolytic uremic syndrome and C3 glomerulopathy
Alba Pau Parra, Natalia Ramos, Janire Perurena-Prieto, Silvia Manrique-Rodríguez, Monica Climente, Laura García Quintanilla, Ángel Escolano, Marta Miarons
Farmacia Hospitalaria.2024; 48(1): T16. CrossRef Monogenic Kidney Diseases in Kidney Transplantation
Valentine Gillion, Arnaud Devresse, Eric Olinger, Géraldine Dahlqvist, Nathalie Demoulin, Nathalie Godefroid, Kathleen Claes, Olivier Devuyst, Nada Kanaan
Kidney International Reports.2024; 9(3): 549. CrossRef Rational use of eculizumab in secondary atypical hemolytic uremic syndrome
Lucía Cordero, Teresa Cavero, Eduardo Gutiérrez, Hernando Trujillo, Justo Sandino, Pilar Auñón, Marta Rivero, Enrique Morales
Frontiers in Immunology.2024;[Epub] CrossRef Die Komplementkaskade in der Nierenpathologie
E. Vonbrunn, C. Daniel
Die Pathologie.2024;[Epub] CrossRef Avacopan for the treatment of ANCA-associated vasculitis: an update
Mohammed Osman, Jan Willem Cohen Tervaert, Christian Pagnoux
Expert Review of Clinical Immunology.2023; 19(5): 461. CrossRef Update on the Application of Monoclonal Antibody Therapy in Primary Membranous Nephropathy
Le Deng, Gaosi Xu
Drugs.2023; 83(6): 507. CrossRef Oxidative stress as a culprit in diabetic kidney disease
Sensen Su, Zhanchuan Ma, Hao Wu, Zhonggao Xu, Huanfa Yi
Life Sciences.2023; 322: 121661. CrossRef Characteristics and management of thrombotic microangiopathy in kidney transplantation
Wonyong Cho, Sang-Kyung Jo, Cheol Woong Jung, Myung-Gyu Kim
Korean Journal of Transplantation.2023; 37(1): 11. CrossRef Pharmacological and clinical profile of ravulizumab 100 mg/mL formulation for paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome
Gema Ariceta
Expert Review of Clinical Pharmacology.2023; 16(5): 401. CrossRef Clinical advances in immunotherapy for immune-mediated glomerular diseases
Bihui Tang, Xiao Yang
Clinical and Experimental Medicine.2023; 23(8): 4091. CrossRef Identification of hub genes and their correlation with immune infiltrating cells in membranous nephropathy: an integrated bioinformatics analysis
Miaoru Han, Yi Wang, Xiaoyan Huang, Ping Li, Xing Liang, Rongrong Wang, Kun Bao
European Journal of Medical Research.2023;[Epub] CrossRef Is There a Place for Complement Inhibition with Monoclonal Anti-C5a Antibody Vilobelimab in the Treatment of Patients with ANCA-associated Vasculitis?
Gatr-Alnada Gheriani, Bharat Kumar, Petar S Lenert
Rheumatology.2022; 1(2): 46. CrossRef
|